New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 7, 2014
07:10 EDTNEONeoGenomics validates and launches new detection test for the CALR gene
NeoGenomics announced that it has validated and launched a new test for the detection of mutations in the calreticulin, or CALR, gene. The CALR gene is a novel biomarker that was reported to be specific for myeloproliferative neoplasms for the first time at the annual meeting of the American Society of Hematology last month. Since then, findings on the CALR gene have been published in the three articles referenced below.
News For NEO From The Last 14 Days
Check below for free stories on NEO the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 17, 2014
13:54 EDTNEONeoGenomics up 21% after reporting Q2 earnings, raising FY14 guidance
Shares of NeoGenomics are trading up 21% in afternoon trading after the company reported Q2 earnings this morning. The company reported in-line earnings, better-than-expected revenue, and raised its FY14 revenue guidance.
07:07 EDTNEONeoGenomics sees 2014 EPS 0c-3c, consensus 3c
Raises 2014 revenue view to $83.0M-$86.0M from $73M-$77M, consensus $78.56M.
07:05 EDTNEONeoGenomics sees Q3 EPS (1c)-1c, consensus 1c
Sees Q3 revenue $22.0M-$22.5M, consensus $20.02M.
07:03 EDTNEONeoGenomics reports Q2 EPS 1c, consensus 1c
Reports Q2 revenue $20.7M, consensus $19.84M.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use